Evidence map›Paper›PMID 39728077›Full record

ReviewJournal of personalized medicine2024

Opportunities and Challenges of Chatbots in Ophthalmology: A Narrative Review.

Mehmet Cem Sabaner, Rodrigo Anguita, Fares Antaki, Michael Balas, Lars Christian Boberg-Ans, Lorenzo Ferro Desideri, Jakob Grauslund, Michael Stormly Hansen, Oliver Niels Klefter, Ivan Potapenko and 2 more

Abstract readReview
In one paragraph

Review in Journal of personalized medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mehmet Cem SabanerDepartment of Ophthalmology, Kastamonu University, Training and Research Hospital, 37150 Kastamonu, Türkiye.ORCID 0000-0002-0958-9961
Rodrigo AnguitaDepartment of Ophthalmology, Inselspital, University Hospital Bern, University of Bern, 3010 Bern, Switzerland.ORCID 0000-0003-2382-1111
Fares AntakiMoorfields Eye Hospital National Health Service Foundation Trust, London EC1V 2PD, UK.ORCID 0000-0001-6679-7276
Michael BalasDepartment of Ophthalmology & Vision Sciences, University of Toronto, Toronto, ON M5T 2S8, Canada.ORCID 0000-0002-5948-0331
Lars Christian Boberg-AnsDepartment of Ophthalmology, Innlandet Hospital Trust, 2382 Brumendal, Norway.
Lorenzo Ferro DesideriDepartment of Ophthalmology, Inselspital, University Hospital Bern, University of Bern, 3010 Bern, Switzerland.
Jakob GrauslundDepartment of Ophthalmology, Odense University Hospital, 5000 Odense, Denmark.ORCID 0000-0001-5019-0736
Michael Stormly HansenDepartment of Ophthalmology, Rigshospitalet, 2100 Copenhagen, Denmark.ORCID 0000-0001-8610-7455
Oliver Niels KlefterDepartment of Ophthalmology, Rigshospitalet, 2100 Copenhagen, Denmark.ORCID 0000-0003-2313-5648
Ivan PotapenkoDepartment of Ophthalmology, Rigshospitalet, 2100 Copenhagen, Denmark.ORCID 0000-0002-7201-655X
Marie Louise Roed RasmussenDepartment of Ophthalmology, Rigshospitalet, 2100 Copenhagen, Denmark.ORCID 0000-0002-9392-8697
Yousif SubhiDepartment of Clinical Research, University of Southern Denmark, 5230 Odense, Denmark.ORCID 0000-0001-6620-5365

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial intelligence (AI) is becoming increasingly influential in ophthalmology, particularly through advancements in machine learning, deep learning, robotics, neural networks, and natural language processing (NLP). Among these, NLP-based chatbots are the most readily accessible and are driven by AI-based large language models (LLMs). These chatbots have facilitated new research avenues and have gained traction in both clinical and surgical applications in ophthalmology. They are also increasingly being utilized in studies on ophthalmology-related exams, particularly those containing multiple-choice questions (MCQs). This narrative review evaluates both the opportunities and the challenges of integrating chatbots into ophthalmology research, with separate assessments of studies involving open- and close-ended questions. While chatbots have demonstrated sufficient accuracy in handling MCQ-based studies, supporting their use in education, additional exam security measures are necessary. The research on open-ended question responses suggests that AI-based LLM chatbots could be applied across nearly all areas of ophthalmology. They have shown promise for addressing patient inquiries, offering medical advice, patient education, supporting triage, facilitating diagnosis and differential diagnosis, and aiding in surgical planning. However, the ethical implications, confidentiality concerns, physician liability, and issues surrounding patient privacy remain pressing challenges. Although AI has demonstrated significant promise in clinical patient care, it is currently most effective as a supportive tool rather than as a replacement for human physicians.

Indexed as

artificial intelligenceBardBingChatGPTClaudee-learningGeminilarge language modelophthalmology

Identifiers

PMID39728077
PMCPMC11678018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.